Anti-inflammatory Effects of Resveratrol on Hypoxia/Reoxygenation-Induced Alveolar Epithelial Cell Dysfunction

Journal of Agricultural and Food Chemistry

Volumn 63, Issue 43, 2015, Pages 9480-9487

  Liu, Po Len ^a   Chong, Inn Wen ^a,b   Lee, Yi Chen ^a   Tsai, Jong Rung ^a,b   Wang, Hui Min ^a   Hsieh, Chong Chao ^b   Kuo, Hsuan Fu ^b   Liu, Wei Lun ^c   Chen, Yung Hsiang ^d,e,f   Chen, Hsiu Lin ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

hypoxia; inflammation; reoxygenation; resveratrol; surfactant

Indexed keywords

CELL CULTURE; CELLS; PATHOLOGY; SURFACE ACTIVE AGENTS; TRANSCRIPTION;

ALVEOLAR EPITHELIAL CELLS; ANTI-INFLAMMATORY EFFECTS; HYPOXIA; INFLAMMATION; INFLAMMATORY CYTOKINES; REOXYGENATION; TRANSCRIPTION ACTIVITY; TYPE II ALVEOLAR EPITHELIAL CELLS;

RESVERATROL;

ANTIINFLAMMATORY AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; OXYGEN; RESVERATROL; STILBENE DERIVATIVE;

ANOXIA; CELL LINE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; HUMAN; IMMUNOLOGY; LUNG ALVEOLUS; LUNG INJURY; METABOLISM;

ANOXIA; ANTI-INFLAMMATORY AGENTS; CELL LINE; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LUNG INJURY; OXYGEN; PULMONARY ALVEOLI; STILBENES;

EID: 84946606887     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b01168     Document Type: Article

References (49)

1. Ferreira, V.; Bueno, M.; Franco-Luesma, E.; Cullere, L.; Fernandez-Zurbano, P. Key changes in wine aroma active compounds during bottle storage of Spanish red wines under different oxygen levels J. Agric. Food Chem. 2014, 62, 10015-27 10.1021/jf503089u
2. Houille, B.; Besseau, S.; Courdavault, V.; Oudin, A.; Glevarec, G.; Delanoue, G.; Guerin, L.; Simkin, A. J.; Papon, N.; Clastre, M.; Giglioli-Guivarc'h, N.; Lanoue, A. Biosynthetic Origin of E-Resveratrol Accumulation in Grape Canes during Postharvest Storage J. Agric. Food Chem. 2015, 63, 1631-8 10.1021/jf505316a
3. Moreno-Labanda, J. F.; Mallavia, R.; Perez-Fons, L.; Lizama, V.; Saura, D.; Micol, V. Determination of piceid and resveratrol in Spanish wines deriving from Monastrell (Vitis vinifera L.) grape variety J. Agric. Food Chem. 2004, 52, 5396-403 10.1021/jf049521m
4. Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discovery 2006, 5, 493-506 10.1038/nrd2060
5. Rivera, L.; Moron, R.; Zarzuelo, A.; Galisteo, M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats Biochem. Pharmacol. 2009, 77, 1053-63 10.1016/j.bcp.2008.11.027
6. Gambini, J.; Ingles, M.; Olaso, G.; Lopez-Grueso, R.; Bonet-Costa, V.; Gimeno-Mallench, L.; Mas-Bargues, C.; Abdelaziz, K. M.; Gomez-Cabrera, M. C.; Vina, J.; Borras, C. Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans Oxid. Med. Cell. Longevity 2015, 2015, 837042 10.1155/2015/837042
7. Pialoux, V.; Mounier, R. Hypoxia-induced oxidative stress in health disorders Oxid. Med. Cell. Longevity 2012, 2012, 940121 10.1155/2012/940121
8. Hwang, B. F.; Magnus, P.; Jaakkola, J. J. K. Seasonal variation of birth defects in Norway BioMedicine 2013, 3, 95-101 10.1016/j.biomed.2013.04.002
9. Mahoney, A. D.; Jain, L. Respiratory disorders in moderately preterm, late preterm, and early term infants Clin. Perinatol. 2013, 40, 665-78 10.1016/j.clp.2013.07.004
10. Martin, T. R. Neutrophils and lung injury: getting it right J. Clin. Invest. 2002, 110, 1603-5 10.1172/JCI0217302
11. Hallman, M. The surfactant system protects both fetus and newborn Neonatology 2013, 103, 320-6 10.1159/000349994
12. Castell, J. V.; Donato, M. T.; Gomez-Lechon, M. J. Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach Exp. Toxicol. Pathol. 2005, 57 (Suppl 1) 189-204 10.1016/j.etp.2005.05.008
13. Sharma, A. K.; Mulloy, D. P.; Le, L. T.; Laubach, V. E. NADPH oxidase mediates synergistic effects of IL-17 and TNF-alpha on CXCL1 expression by epithelial cells after lung ischemia-reperfusion Am. J. Physiol. Lung Cell Mol. Physiol. 2014, 306, L69-79 10.1152/ajplung.00205.2013
14. Goodman, R. B.; Pugin, J.; Lee, J. S.; Matthay, M. A. Cytokine-mediated inflammation in acute lung injury Cytokine Growth Factor Rev. 2003, 14, 523-35 10.1016/S1359-6101(03)00059-5
15. Hallman, M.; Glumoff, V.; Ramet, M. Surfactant in respiratory distress syndrome and lung injury Comp. Biochem. Physiol., Part A: Mol. Integr. Physiol. 2001, 129, 287-94 10.1016/S1095-6433(01)00324-5
16. Lin, F. Y.; Chen, Y. H.; Chen, Y. L.; Wu, T. C.; Li, C. Y.; Chen, J. W.; Lin, S. J. Ginkgo biloba extract inhibits endotoxin-induced human aortic smooth muscle cell proliferation via suppression of toll-like receptor 4 expression and NADPH oxidase activation J. Agric. Food Chem. 2007, 55, 1977-84 10.1021/jf062945r
17. Wang, S. H.; Lin, S. J.; Chen, Y. H.; Lin, F. Y.; Shih, J. C.; Wu, C. C.; Wu, H. L.; Chen, Y. L. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor Arterioscler., Thromb., Vasc. Biol. 2009, 29, 816-22 10.1161/ATVBAHA.109.184739
18. Giard, D. J.; Aaronson, S. A.; Todaro, G. J.; Arnstein, P.; Kersey, J. H.; Dosik, H.; Parks, W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors J. Natl. Cancer Inst. 1973, 51, 1417-23 10.1093/jnci/51.5.1417
19. Roggen, E. L.; Soni, N. K.; Verheyen, G. R. Respiratory immunotoxicity: an in vitro assessment Toxicol. In Vitro 2006, 20, 1249-64 10.1016/j.tiv.2006.03.009
20. Rui, T.; Cepinskas, G.; Feng, Q.; Kvietys, P. R. Delayed preconditioning in cardiac myocytes with respect to development of a proinflammatory phenotype: role of SOD and NOS Cardiovasc. Res. 2003, 59, 901-911 10.1016/S0008-6363(03)00502-9
21. Lin, F. Y.; Lin, Y. W.; Huang, C. Y.; Chang, Y. J.; Tsao, N. W.; Chang, N. C.; Ou, K. L.; Chen, T. L.; Shih, C. M.; Chen, Y. H. GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, induces lectin-like oxidized low-density lipoprotein receptor 1 expression in endothelial cells and enhances atherogenesis in hypercholesterolemic rabbits J. Immunol. 2011, 186, 4405-14 10.4049/jimmunol.1003116
22. Chen, H. Y.; Lin, W. Y.; Chen, Y. H.; Chen, W. C.; Tsai, F. J.; Tsai, C. H. Matrix metalloproteinase-9 polymorphism and risk of pelvic organ prolapse in Taiwanese women Eur. J. Obstet. Gynecol. Reprod. Biol. 2010, 149, 222-4 10.1016/j.ejogrb.2009.12.014
23. Chen, Y. H.; Liu, H. P.; Chen, H. Y.; Tsai, F. J.; Chang, C. H.; Lee, Y. J.; Lin, W. Y.; Chen, W. C. Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis/urolithiasis Kidney Int. 2011, 80, 369-77 10.1038/ki.2011.80
24. Tsai, J. R.; Wang, H. M.; Liu, P. L.; Chen, Y. H.; Yang, M. C.; Chou, S. H.; Cheng, Y. J.; Yin, W. H.; Hwang, J. J.; Chong, I. W. High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients Cell. Oncol. 2012, 35, 461-71 10.1007/s13402-012-0105-5
25. Chen, W. C.; Wu, S. Y.; Liu, H. P.; Chang, C. H.; Chen, H. Y.; Chen, H. Y.; Tsai, C. H.; Chang, Y. C.; Tsai, F. J.; Man, K. M.; Liu, P. L.; Lin, F. Y.; Shen, J. L.; Lin, W. Y.; Chen, Y. H. Identification of melamine/cyanuric acid-containing nephrolithiasis by infrared spectroscopy J. Clin. Lab. Anal. 2010, 24, 92-9 10.1002/jcla.20362
26. Huerta, L.; Rancan, L.; Simon, C.; Isea, J.; Vidaurre, E.; Vara, E.; Garutti, I.; Gonzalez-Aragoneses, F. Ischaemic preconditioning prevents the liver inflammatory response to lung ischaemia/reperfusion in a swine lung autotransplant model Eur. J. Cardiothorac. Surg. 2013, 43, 1194-201 10.1093/ejcts/ezs599
27. Farivar, A. S.; Woolley, S. M.; Fraga, C. H.; Byrne, K.; Mulligan, M. S. Proinflammatory response of alveolar type II pneumocytes to in vitro hypoxia and reoxygenation Am. J. Transplant. 2004, 4, 346-51 10.1111/j.1600-6143.2004.00352.x
28. Zhang, C.; Lin, G.; Wan, W.; Li, X.; Zeng, B.; Yang, B.; Huang, C. Resveratrol, a polyphenol phytoalexin, protects cardiomyocytes against anoxia/reoxygenation injury via the TLR4/NF-kappaB signaling pathway Int. J. Mol. Med. 2012, 29, 557-63 10.3892/ijmm.2012.885
29. Driessler, F.; Venstrom, K.; Sabat, R.; Asadullah, K.; Schottelius, A. J. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50 Clin. Exp. Immunol. 2004, 135, 64-73 10.1111/j.1365-2249.2004.02342.x
30. Dudley, J.; Das, S.; Mukherjee, S.; Das, D. K. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose J. Nutr. Biochem. 2009, 20, 443-52 10.1016/j.jnutbio.2008.05.003
31. Liu, P. L.; Tsai, J. R.; Charles, A. L.; Hwang, J. J.; Chou, S. H.; Ping, Y. H.; Lin, F. Y.; Chen, Y. L.; Hung, C. Y.; Chen, W. C.; Chen, Y. H.; Chong, I. W. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases Mol. Nutr. Food Res. 2010, 54 (Suppl 2) S196-S204 10.1002/mnfr.200900550
32. Gescher, A.; Steward, W. P.; Brown, K. Resveratrol in the management of human cancer: how strong is the clinical evidence? Ann. N. Y. Acad. Sci. 2013, 1290, 12-20 10.1111/nyas.12205
33. Walle, T.; Hsieh, F.; DeLegge, M. H.; Oatis, J. E., Jr.; Walle, U. K. High absorption but very low bioavailability of oral resveratrol in humans Drug Metab. Dispos. 2004, 32, 1377-1382 10.1124/dmd.104.000885
34. Belguendouz, L.; Fremont, L.; Linard, A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins Biochem. Pharmacol. 1997, 53, 1347-55 10.1016/S0006-2952(96)00820-9
35. Jannin, B.; Menzel, M.; Berlot, J. P.; Delmas, D.; Lancon, A.; Latruffe, N. Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake Biochem. Pharmacol. 2004, 68, 1113-8 10.1016/j.bcp.2004.04.028
36. Gautam, A.; Koshkina, N. Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery Curr. Cancer Drug Targets 2003, 3, 287-96 10.2174/1568009033481912
37. Yoshida, M.; Korfhagen, T. R.; Whitsett, J. A. Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways J. Immunol. 2001, 166, 7514-9 10.4049/jimmunol.166.12.7514
38. Condon, J. C.; Jeyasuria, P.; Faust, J. M.; Mendelson, C. R. Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 4978-83 10.1073/pnas.0401124101
39. Mason, R. J. Biology of alveolar type II cells Respirology 2006, 11 (Suppl) S12-5 10.1111/j.1440-1843.2006.00800.x
40. Andreeva, A. V.; Kutuzov, M. A.; Voyno-Yasenetskaya, T. A. Regulation of surfactant secretion in alveolar type II cells Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293, L259-71 10.1152/ajplung.00112.2007
41. Rucka, Z.; Vanhara, P.; Koutna, I.; Tesarova, L.; Potesilova, M.; Stejskal, S.; Simara, P.; Dolezel, J.; Zvonicek, V.; Coufal, O.; Capov, I. Differential effects of insulin and dexamethasone on pulmonary surfactant-associated genes and proteins in A549 and H441 cells and lung tissue Int. J. Mol. Med. 2013, 32, 211-8 10.3892/ijmm.2013.1363
42. Sakamoto, T.; Hirano, K.; Morishima, Y.; Masuyama, K.; Ishii, Y.; Nomura, A.; Uchida, Y.; Ohtsuka, M.; Sekizawa, K. Maintenance of the differentiated type II cell characteristics by culture on an acellular human amnion membrane In Vitro Cell. Dev. Biol. Anim. 2001, 37, 471-9 10.1290/1071-2690(2001)037<0471:MOTDTI>2.0.CO;2
43. George, U. M.; Ashna, U.; Kumar, S. S.; Nandkumar, A. M. Effect of tobacco extract on surfactant synthesis and its reversal by retinoic acid-role of cell-cell interactions in vitro In Vitro Cell. Dev. Biol.: Anim. 2013, 49, 260-9 10.1007/s11626-013-9595-3
44. Foster, K. A.; Oster, C. G.; Mayer, M. M.; Avery, M. L.; Audus, K. L. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism Exp. Cell Res. 1998, 243, 359-66 10.1006/excr.1998.4172
45. Hoshino, Y.; Mio, T.; Nagai, S.; Miki, H.; Ito, I.; Izumi, T. Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 281, L509-L516
46. Wu, Y.; Lv, J.; Feng, D.; Jiang, F.; Fan, X.; Zhang, Z.; Yin, R.; Xu, L. Restoration of alveolar type II cell function contributes to simvastatin-induced attenuation of lung ischemia-reperfusion injury Int. J. Mol. Med. 2012, 30, 1294-306 10.3892/ijmm.2012.1161
47. Neuringer, I. P.; Randell, S. H. Stem cells and repair of lung injuries Respir. Res. 2004, 5, 6 10.1186/1465-9921-5-6
48. Wang, D.; Haviland, D. L.; Burns, A. R.; Zsigmond, E.; Wetsel, R. A. A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 4449-54 10.1073/pnas.0700052104
49. Bhaskaran, M.; Kolliputi, N.; Wang, Y.; Gou, D.; Chintagari, N. R.; Liu, L. Trans-differentiation of alveolar epithelial type II cells to type I cells involves autocrine signaling by transforming growth factor beta 1 through the Smad pathway J. Biol. Chem. 2007, 282, 3968-3976 10.1074/jbc.M609060200